Literature DB >> 16467951

Psychiatric disorders certified on death certificates in an English population.

Michael J Goldacre1, Marie E Duncan, Myfanwy Griffith, Paula Cook-Mozaffari.   

Abstract

BACKGROUND: Psychiatric disorders are sometimes certified on death certificates, but seldom selected as the underlying cause of death. The majority of deaths with a certified psychiatric cause are usually omitted from official mortality statistics, which are typically based on the underlying cause alone. AIM: To report on death rates for psychiatric disorders, as certified on death certificates, including all mentioned causes as well as the underlying cause of death.
METHOD: Analysis of database including all certified causes of death in 1979-1999, in three time periods defined by coding rule changes.
RESULTS: Statistics on the underlying cause of death grossly under-estimated certified psychiatric disorders. For example, in the first period of our study they missed 88% of deaths in which schizophrenia was a certified cause, 98% of affective psychosis, and 96% of depression. Over time, considering all certified causes, age-standardised death rates for schizophrenia declined, those for affective psychosis showed no change, and those for depression and dementia increased.
CONCLUSION: The decline in mortality rates for schizophrenia, and the increase for depression and dementia, may reflect real changes over time in disease prevalence at death, although other explanations are possible and are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16467951     DOI: 10.1007/s00127-006-0035-5

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  8 in total

1.  Trends in mortality rates comparing underlying-cause and multiple-cause coding in an English population 1979-1998.

Authors:  Michael J Goldacre; Marie E Duncan; Paula Cook-Mozaffari; Myfanwy Griffith
Journal:  J Public Health Med       Date:  2003-09

2.  Is schizophrenia disappearing?

Authors:  G Der; S Gupta; R M Murray
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

3.  Decline in the diagnosis of schizophrenia among first contacts with psychiatric services in north-east Scotland, 1969-1984.

Authors:  J M Eagles; D Hunter; C McCance
Journal:  Br J Psychiatry       Date:  1988-06       Impact factor: 9.319

4.  Trends in episode based and person based rates of admission to hospital in the Oxford record linkage study area.

Authors:  M J Goldacre; H Simmons; J Henderson; L E Gill
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

5.  Persistence of the decline in the diagnosis of schizophrenia among first admissions to Scottish hospitals from 1969 to 1988.

Authors:  J R Geddes; R J Black; L J Whalley; J M Eagles
Journal:  Br J Psychiatry       Date:  1993-11       Impact factor: 9.319

6.  Death certification after a diagnosis of presenile dementia.

Authors:  A J Newens; D P Forster; D W Kay
Journal:  J Epidemiol Community Health       Date:  1993-08       Impact factor: 3.710

7.  Estimating incidence and prevalence of treated psychiatric disorders from routine statistics: the example of schizophrenia in Oxfordshire.

Authors:  M Goldacre; R Shiwach; D Yeates
Journal:  J Epidemiol Community Health       Date:  1994-06       Impact factor: 3.710

8.  Dementia in people aged 65 years and older: a growing problem?

Authors:  L Kirby; P Lehmann; A Majeed
Journal:  Popul Trends       Date:  1998
  8 in total
  10 in total

1.  Effect of comorbid alcohol and drug use disorders on premature death among unipolar and bipolar disorder decedents in the United States, 1999 to 2006.

Authors:  Young-Hee Yoon; Chiung M Chen; Hsiao-Ye Yi; Howard B Moss
Journal:  Compr Psychiatry       Date:  2010-12-13       Impact factor: 3.735

2.  Using multiple-cause-of-death data as a complement of underlying-cause-of-death data in examining mortality differences in psychiatric disorders between countries.

Authors:  Tsung-Hsueh Lu; Jin-Jia Lin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-02       Impact factor: 4.328

3.  Neuroepidemiology: The increasing burden of mortality from neurological diseases.

Authors:  Julia Pakpoor; Michael Goldacre
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

4.  Trend in rates for deaths with mention of schizophrenia on death certificates of US residents, 1999-2010.

Authors:  Anthony P Polednak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-23       Impact factor: 4.328

5.  Trends in bipolar disorder or depression as a cause of death on death certificates of US residents, 1999-2009.

Authors:  Anthony P Polednak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-11-18       Impact factor: 4.328

6.  US regional differences in death rates from depression.

Authors:  Anthony P Polednak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-19       Impact factor: 4.328

7.  Risk of Schizophrenia and Bipolar Disorder in Patients With Multiple Sclerosis: Record-Linkage Studies.

Authors:  Ute-Christiane Meier; Sreeram V Ramagopalan; Michael J Goldacre; Raph Goldacre
Journal:  Front Psychiatry       Date:  2020-07-16       Impact factor: 4.157

8.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.

Authors:  Michael J Goldacre; Marie Duncan; Myfanwy Griffith; Martin R Turner
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

9.  Mortality associated with depression: a forty-year perspective from the Stirling County Study.

Authors:  Jane M Murphy; Jack D Burke; Richard R Monson; Nicholas J Horton; Nan M Laird; Alain Lesage; Arthur M Sobol; Alexander H Leighton
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-03-07       Impact factor: 4.328

10.  Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006.

Authors:  Uy Hoang; Robert Stewart; Michael J Goldacre
Journal:  BMJ       Date:  2011-09-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.